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A one-step microfluidic system is developed in this study which enables the encapsulation of stem cells and
genetically engineered non-pathogenic bacteria into a so-called three-dimensional (3D) pearl lace–like microgel of
alginate with high level of monodispersity and cell viability. The alginate-based microgel constitutes living ma-
terials that control stem cell differentiation in either an autonomous or heteronomous manner. The bacteria
(Lactococcus lactis) encapsulated within the construct surface display adhesion fragments (III7-10 fragment of
human fibronectin) for integrin binding while secreting growth factors (recombinant human bone morphogenetic
protein-2) to induce osteogenic differentiation of human bone marrow–derived mesenchymal stem cells. We
concentrate on interlinked pearl lace microgels that enabled us to prototype a low-cost 3D bioprinting platform
with highly tunable properties.1. Introduction
Cells in tissues of multicellular organisms are enclosed in networks
made of proteins and polysaccharides called the extracellular matrix
(ECM). In addition to the physical support that it provides for tissues, the
ECM initiates crucial biochemical and biomechanical cues required for
the survival, development, migration, proliferation, shape, and function
of cells that are embedded. It is a dynamic network which often gets
remodeled by the cells inhabiting it [1].
Hydrogels as synthetic matrices have received considerable interest
for biomaterial applications owning to their compositional and structural
similarities to the natural ECM [2]. They make three-dimensional (3D)
networks composed of hydrophilic polymers cross-linked either through
covalent bonds or held together via physical intramolecular and inter-
molecular interactions [3,4]. Alginate has been one of the more exten-
sively investigated and used hydrogels in biomedical applications. It is a
naturally occurring anionic polymer with a high biocompatibility, low
cytotoxicity, relatively low cost, and mild cross-linking by addition of
divalent cations such as calcium [5]. A major challenge in tissue engi-
neering is the diffusion limit of 100–200 μm for oxygen as well as nu-
trients and essential biomolecules to the cell population embedded in the
hydrogels [2,6]. One way to overcome the diffusion limitation, besides
vascularization [7], is to assemble small (sub-mm), cell-containing
modules to form larger tissue constructs with homogeneous materialow.ac.uk (M. Salmeron-Sanchez)
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vier Ltd. This is an open access aproperties [8,9]. Most cell microencapsulation techniques are based on
droplet extrusion methods, where cells are mixed with the alginate so-
lution and then extruded through a needle, forming droplets of varying
sizes and population densities which are collected in a gelling medium
usually containing Ca2þ [6].
The use of microfluidics, however, allows for the formation of
monodisperse microcapsules [10,11] or fibrous constructs [12,13] with
fine control over cell population density and coculture of cell populations
in well-defined mixing ratio. The rapid ion exchange between calcium
and alginate results in a fast gel formation, and current microfluidic
methods to produce microcapsules are carried out in complex multistep
processes [10,11]. In case of fibrous constructs, reported fabrication
methods involve extruding long thread-like structures made of alginate
while keeping it sheathed and polymerized by a secondary aqueous so-
lution carrying other biopolymers such as gelatine [14] and sucrose [15]
together with Ca2þ. In contrast, we developed a one-step droplet
microfluidic method for fabrication of cell-laden pearl lace microgels
made from alginate which is performed at physiological pH without
using sheathing material to preserve cell viability. The level of fluid shear
stress experienced by cells as they travel through the capillary channel
can influence their viability and mechanosensitivity. For instance, me-
chanically induced activation of signaling pathways by shear stress af-
fects cell behavior [16] or their plasticity in case of stem cells [17,18]. We
addressed this issue in our microfluidic device by choosing appropriate.
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The fabricated gel construct is unique in a way that it has both
compartmentalized units as in individual microcapsules as well as the
connectivity found in fibrous constructs. It is also noted that the com-
partmentalized microunits and the link connecting them are highly
tunable resulting in highly monodispersed pearl lace interlinking struc-
tures. Inherent to the fabrication process, the pearl unit compared to the
interlinking unit benefit from a slower cross-linking in addition to a
dampened shear stress. This technology allows manufacturing compart-
mentalized yet linked cell-laden hydrogels with unprecedented precision
and control [19–21] which has been exploited here as a low-cost 3D
bioprinting prototype.
As a proof of concept, we have used this microfluidic technology to
automate fabrication of an in vitro 3D model for investigating the
commensalism symbiosis between eukaryotic (human bone mar-
row–derived mesenchymal stem cells [hBM-MSCs]) and prokaryotic cells
(engineered non-pathogenic bacteria Lactococcus lactis).
Bacteria are long being utilized as a fast and low-cost production
organism of proteins and glycoproteins of biomedical interest [22–26].
As it has been demonstrated by Hay et al., they can also be used to
provide a spatiotemporal requested proteins and factors to direct cell
proliferation and differentiation. For instance, bone morphogenetic
protein-2 (BMP-2), a well-known growth factor for inducing new bone
formation [27], has been engineered to be released in a controllable
fashion by L. lactis to create a dynamic functional living biointerphases
between synthetic materials and living cells [28,29]. In addition to
release of BMP-2 (protein of interest), L. lactis's surface was engineered to
accommodate as the binding site for integrins by incorporating argini-
ne-glycine-arpartic acid (RGD)-containing motif of fibronectin (FN). FN
mediates a wide variety of cellular interactions with the ECM and plays
important roles in cell adhesion, migration, growth, and differentiation
[27,30,31]. Because MSCs do not have receptors that recognize alginate,
in this study, the combination of these two proteins and their synergistic
effect on differentiation for modeling a micron-sized 3D model of
osteogenesis were explored.
The homofermentative metabolism of L. lactis in presence of a suitable
carbon source leads to a buildup of lactic acid, therefore acidifying the
media which is detrimental to MSC viability. To prevent acidification due
to the accumulation of lactic acid within the microparticles, a lactate
dehydrogenase (LDH)–deficient strain of L. lactis, NZ9020, was used
[32]. LDH, which metabolizes pyruvate to lactic acid, is the last enzyme
in the homofermentative glycolytic (Embden–Meyerhof–Parnas)
pathway characteristic of the lactic acid bacteria clade [32]. To prevent
bacterial proliferation inside the microgels, sulfamethoxazole (SMX), a
bacteriostatic antibiotic that prevents folic acid synthesis, was used. Note
that mammalian cells, unable to synthesize folic acid, are insensitive to
this antibiotic [33]. In one study, it has been reported that SMX in
combination with trimethoprim antibiotic reduces peripheral blood stem
cell mobilization while not affecting the quantity of the cell assessed
[34]. In studies by Hay et al. [28], the low concentration of SMX alone
concluded no adverse effect on MSC viability and its osteogenic differ-
entiation; however, the mobility of the cells was not investigated.
2. Material and methods
2.1. L. lactis cell culture
Two transformants of L. lactis (ldhA and ldhB) were engineered
[28]. One of the transformants contained a constitutive expression vector
carrying the gene for FNIII7-10 fragment. The other one contained a
constitutive expression vector carrying the gene for BMP-2. The two
vectors had chloramphenicol resistance gene. Bacteria were cultured at
30 C in anaerobic conditions, in M17 medium (Oxoid, Basingstoke, UK)
supplemented with glucose (0.5% v/v, Sigma), erythromycin (10 μg/mL,
Sigma-Aldrich), and chloramphenicol (10 μg/mL, Sigma-Aldrich). Same
gene constructs cloned in nisin-inducible plasmids containing2chloramphenicol resistance gene were used for inducible studies. Daily
change of media with 10 ng/mL nisin was used for inducing protein
expression of BMP-2 and FNIII7-10.
2.2. Human MSC culture
Dulbecco's Modified Eagle Medium (DMEM) (PromoCell GmbH)
supplemented with 4.5 g/L glucose, 100 μM sodium pyruvate, 1 mM L-
glutamine, 10% fetal bovine serum (FBS), and 100 U/mL penicillin/
streptomycin was used for maintaining hBM-MSCs (Promocell). Cultures
were kept at 37 C and 5% CO2 in a humidified atmosphere. Media was
changed every 2–3 days. For experimental use, MSCs were maintained
between passages p2 and 4.
2.3. L. lactis and MSC coculture
MSC media was changed to DMEM supplemented with 2% FBS, 1 g/L
glucose, 100 μM sodium pyruvate, 1 mM L-glutamine, and 10 μ g/mL
chloramphenicol, and in order to inhibit bacterial metabolism and con-
trol media acidification, 10 μg/mL SMX and 10 μg/mL tetracycline were
added. Cultures were kept at 37 C and 5% CO2 in a humidified atmo-
sphere. Encapsulated cells were cultured for two weeks with media being
changed every day. Osteogenic media was prepared by supplementing
DMEM with 2% FBS, 1 g/L glucose, 100 μM sodium pyruvate, 1 mM L-
glutamine, 25 μg/ml L-ascorbic acid, 0.1 μM dexamethasone, 3 mM
NaH2PO4, and 100 U/mL P/S. Encapsulated MSCs were cultured for two
weeks with media being changed every 2–3 days.
2.4. Microfluidic fabrication
Septum theta (TST150-6) with 1.5/1.02 outer diameter (OD)/inner
diameter (ID) (mm) and thin wall round glass capillaries (TW100-6) with
1/0.75 OD/ID (mm), purchased from World Precision Instruments, Inc.,
were tapered (0.4 mm diameter orifice) using a Sutter Instruments model
P-97 micropipette puller. Larger diameters of tapered tips were made
using sand paper. Smaller sizes of tapered tips were made manually by
pulling locally heated capillaries. Square capillary of 2 mm  6% ID with
wall thickness of 0.4 mm was purchased from World Precision In-
struments, Inc. Capillary surfaces were modified with hydrophobic Sig-
macote (Sigma-Aldrich). Silica capillaries were first cleaned by soaking
in a piranha solution (3:1 sulfuric acid:hydrogen peroxide) for 20 min,
followed by rinsing with deionized water and drying with nitrogen gas.
The treated capillaries were rinsed with isopropanol and dried with ni-
trogen gas. The device was fabricated by coaxially aligning two round
capillaries with tapered ends facing each other inside a square capillary
as shown in Fig. 1A. One of the two round capillaries had a theta
ϴ-shaped cross section with OD of 2.00 0.10 mm and ID of 1.40 0.10
mm. The other round capillary is hollow with OD of 1.80 mm and ID of
1.50 mm. The square capillary inner width is 2.00 mm with wall thick-
ness of 0.40 mm. Each of the two theta-shaped capillary channels was
connected to polytetrafluoroethylene (PTFE) soft tubing via small cap-
illaries inserted from the untapered end for introducing aqueous solu-
tions into the device in a synchronous manner (Fig. 1B). The microfluidic
device was coupled with controllable syringe pumps (Harvard Appa-
ratus) for fluid delivery.
2.5. Cell encapsulation
L. lactis and MSCs were individually resuspended in DMEM supple-
mented with 2% FBS, 1 g/L glucose, 100 μM sodium pyruvate, 1 mM L-
glutamine, and 10 μ g/mL chloramphenicol. Cells were then pooled and
mixed 1:1 with solution containing 4% (w/v) medium viscosity sodium
alginate (Sigma-Aldrich, UK) in order to make a 2% alginate solution.
Cell mixture with alginic acid was introduced into the device via one of
the two channels of theta-shaped capillaries and 200 mM calcium chlo-
ride solution from the other channel. Mineral oil (Sigma-Aldrich) with
K. Witte et al. Materials Today Bio 2 (2019) 1000112% Span 80 (Sigma-Aldrich) was pumped through a square capillary in
order to form the continuous phase. Dispersed hydrogel droplets were
collected in a prewarmed culture media, followed by washing with 100
mM calcium chloride and culturing in DMEM media supplemented with
2% FBS, 1 g/L glucose, 100 μM sodium pyruvate, 1 mM L-glutamine, 10
μg/mL chloramphenicol, 10 μg/mL SMX, and 10 μg/mL tetracycline at
37 C and 5% CO2 in a humidified atmosphere. Media was changed every
day for gels containing bacteria and every 2–3 days for gels containing
MSCs only.2.6. Viability assay
For bacterial viability studies, alginate constructs embedded with
cells were washed twice with 100 mM calcium chloride solution prior to
incubation with 5 μM SYTO® 9 and 30 μM Propidium iodide (BacLight
LIVE/DEAD kit, Life Technologies, UK) in 100 mM calcium chloride so-
lution for an hour at 37 C. For mammalian cell viability studies,
encapsulated cells in hydrogel were incubated in a 100 mM calcium
chloride solution containing 2 μM calcein and 2 μM ethidium
homodimer-1 (Viability/Cytotoxicity Kit, Life Technologies) for an hourFig. 1. Droplet-based microfluidic setup. (A) Schematic representation of the micr
of the capillary-based microfluidic device. (C) A snapshot of pearl formation in micr
(D) Thread thickness graph with corresponding flow rates (Y-axis: water flow; X-axi
3at 37 C. Viability was calculated by analyzing the total amount of cells
stained in green versus the number of cells stained in red and green. The
distribution of live cells (green) and dead cells (red) was visualized using
EVOS Fl Colour Cell Imaging System and software. Acquired images were
analyzed by quantifying pixel intensities of the fluorescence signals using
the ImageJ software version 1.51 (100) and plotted using GraphPad
Prism (version 7.0 software). Merged fluorescence channel images were
processed using the same version of the ImageJ software.2.7. Immunofluorescence
Hydrogel constructs containing cells were washed twice in 100 mM
calcium chloride before getting fixed in 4% (w/v) paraformaldehyde for
30 min at room temperature. Samples were permeabilised in 0.01% (v/v)
Triton X-100 for 30 min and blocked with 1% bovine serum albumin
(BSA) in 100 mM calcium chloride for an hour at room temperature.
Samples were then incubated overnight with the following primary an-
tibodies: osteocalcin (OCN, mouse monoclonal, sc-365797, UK) or
osteopontin (OPN, mouse monoclonal, sc-21742, UK) (Santa Cruz
Biotechnology, UK) diluted 1:50 in 100 mM calcium chloride, 1% BSA.ofluidic device and encapsulation of prokaryotic and eukaryotic cells. (B) Image
ofluidic device with indication of parameters used to quantify assembled pearls.
s: oil flow). (E) Thread thickness graph. (F) Pearl area graph.
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Tween 20 in 100 mM calcium chloride for 5 min each wash before in-
cubation with a secondary, biotin-conjugated antibody (monoclonal
rabbit anti-mouse [IgG], Vector Laboratories, UK) diluted 1:50 in 100
mM calcium chloride, 1% BSA. Dilution of 1:50 Alexa Fluor 488-conju-
gated phalloidin (Life Technologies) was added to the samples for the
duration of this incubation. Samples were then washed three times with
0.5% Tween 20 in 100 mM calcium chloride for 5 min each wash.
Samples were incubated with 1:50 dilution of rhodamine-conjugated
streptavidin (Vector Laboratories) and 0.03 mM PureBlu Nuclear Stain-
ing (Bio-Rad, UK) in 100 mM calcium chloride, 1% BSA for 30 min at 4
C. Hydrogels were then washed three times with 0.5% Tween 20 in 100
mM calcium chloride for 5 min each wash prior to fluorescence imaging
using a Zeiss AxioObserver- Z1 microscope or EVOS Fl Colour Cell Im-
aging System and software. Acquired images were analyzed with ImageJ
as described previously.
2.8. Scanning electron microscopy
Hydrogel constructs containing cells were washed twice in 100 mM
calcium chloride before getting fixed in 4% (w/v) paraformaldehyde for
an hour at room temperature. Fixed hydrogel samples were washed three
times for 5 min each wash with 0.15 M sodium cacodylate and incubated
in 1% osmium tetroxide, 0.15 M sodium cacodylate buffer for an hour at
room temperature. Samples were then washed five times in distilled
water before dehydration through an ethanol series beginning with 30%
and changing to solutions of 50%, 70%, 90%, and three times 100%, over
30 min. Samples were then dried with a Polaron E3000 Critical Point
Dryer (supercritical CO2) for 80 min. Prior to imaging, samples were
sputter coated with 1–2 nm gold-palladium using a POLARON SC515
SEM Coater. Samples were imaged in a JEOL 6400 SEM with a gun
voltage acceleration of 10 kV.
2.9. Transmission electron microscopy
Similar to scanning electron microscopy, samples were dehydrated
with ethanol solutions of 50%, 70%, 90%, and three times 100%, over 30
min prior to be washed with propylene oxide three times each for
duration of 5 min. They were then mixed in 1:1 propylene oxide: Epon
812 resin overnight as propylene oxide evaporates. Samples were
changed to fresh resin, embedded in flat bed molds and polymerized for
48 h at 60 C. 60–70 nm ultrathin sections were produced using Leica
Ultracut UCT and a Diatome diamond knife at an angle of 6 C. Sample
sections were picked up on 100 mesh formvar coated copper grids then
contrast stained with 2% methanolic uranyl acetate for 5 min and Rey-
nolds lead citrate for another 5 min. Samples were viewed on JEOL 1200
TEM at an accelerating voltage of 80 kV. TIF images were captured using
Olympus iTEM soft imaging system.
2.10. 3D printing
Four simple geometrical shapes (line, triangle, square, and circle)
were made from poly(methyl methacrylate) (PMMA) using HPC laser
cutter. The 3 mm in diameter circle discs were laser cut through 3.00
mm acrylic sheet and glued using epoxy on a second 3.0 mm acrylic
sheet. The arrangement of discs for making each of the four shapes was
as follow: 2 circular discs for line (180-degree angle); 3 for triangle (60-
degree internal angle); 4 for square (90-degree internal angle), and 8
(135-degree internal angle, octagon) for a circle-like shape. One-micron-
sized green (450/480) fluorescent polystyrene microspheres (Thermo
Scientific™ Fluoro-Max) were encapsulated within alginate pearl lace
construct. While the construct being continuously fabricated and
collected from the microfluidic device, it was getting perpendicularly
wrapped around the pillars (circular discs) after going through an
aqueous solution (100 mM calcium chloride) and leaving behind min-
eral oil. Between two to four turns were made around each pillar. The4bright-field and fluorescent images were taken by scanning over a 30 
30 mm square using EVOS FL Colour Cell Imaging System at 10X
objective and stitched together using EVOS owns software. The hydro-
gels were air-dried prior to imaging.
2.11. Statistical analysis
Data were presented as mean values, standard deviations, and/or
standard error. Mean values were calculated from two independent ex-
periments of triplicates by group. Statistical analysis was performed by
one-way analysis of variance followed by a Tukey post hoc test in
GraphPad Prism™ 6 software using a level of significance of p < 0.1 (*),
p < 0.05 (**), p < 0.001 (***), and p < 0.0001 (****).
3. Results and discussion
3.1. Microfluidic fabrication of monodispersed alginate microgels
The production of alginate microgels was carried out via single-step
emulsification in 3D (axisymmetric) flow focusing glass capillary
microfluidic devices. The device design is based on a previous design by
Lee et al. [11]; however, and importantly, the formation of the alginate
construct in this report is fundamentally different and is performed
within a single step as oppose to their reported three-step formation of
microgels. Each of the two channels of theta ϴ-shaped capillaries carries
aqueous solutions, one carries 2% (w/v) sodium alginate and the other
one carries 100 mM calcium chloride. At the tapered end, the two
aqueous fluids meet and form microgels while simultaneously getting
dispersed in mineral oil with 2% Span 80 pumped through via the square
capillary. The hollow round capillary at the other end of the device is the
outlet for the formed hydrogel construct and its carrier oil. Microgels
then collected in 100 mM calcium chloride solution as the hydrogel sink
and the less-dense oil (density of 0.84 g mL1) and surfactant float on top
of the solution.
Different sizes of microgels were made by changing the flow rate of
oil and water phase as shown in Fig. 1C–F. But once a set of flow rates
were selected, the formed microgels were monodispersed in shape and
size (Fig. 2A). Two distinctive microgels namely unlinked and linked
pearl-shaped beads were made by altering the flow rates (Figs. S1(A and
B) and Supplementary Videos 1 and 2).
Supplementary video related to this article can be found at https://
doi.org/10.1016/j.mtbio.2019.100011
Individual beads were made at relatively low flow rates (100–200 μL
h1 for water phase and 1000–2000 μL h1 for oil phase) as compared to
those of linked pearl beads (300–1000 μL h1 for water and 3000–10000
μL h1 for oil). The physical characteristics of linked pearl beads such as
size, the distance, and the thickness of the link between two pearl beads
can be fine-tuned by controlling the ratio between water to oil flow rates.
For example, by increasing the rate of the oil phase, the thread linking two
pearls can get extended (Fig. 1D). The same outcome can also be achieved
by reducing the rate of thewater phase. In a similar way, by increasing the
flow rate of the oil phase, the thread thickness (Fig. 1E) and the pearl area
(Fig. 1F) decrease in size, which can also be achieved by reducing the flow
rate of the water phase. Furthermore, by reducing the rate of both water
and oil phases, the link between pearls will not form, hence resulting in
unlinked beads. The production rate of the hydrogels ranges from 10 to
100 units per second based on selected flow rates.
3.2. Encapsulation and viability of bacteria and MSCs in micron-sized
hydrogels
Microfluidics provides a high throughput technology for encapsula-
tion of different cell types as compared to more conventional and labo-
rious methods, which provide low yield. A similar construct to pearl lace
microgel has reported using in-air microfluidics [35]. However, owing to
the fabrication nature of in-air microfluidic platform, constructs were
Fig. 2. Monodispersity, encapsulation,
and viability of microbeads. (A) Pearl size
(long axis) distribution of produced hydrogel
of two miscible fluid streams under laminar
flow conditions using flow rates of 500 μL
h1 for the two inner phases and 5000 μL h1
for the outer phase. The mean length of the
formed pearl was 167 μm with an RSD of
3.2%. Scale bar: 100 μm. (B) Cell (MSCs and
L. lactis) encapsulation efficiency. The cell
counts at each time point are the result of 8
measurements sequentially acquired at 30-
min intervals at room temperature for 2 h.
(C) Fluorescent images of two-week-old
alginate hydrogels with L. lactis and MSCs.
The hydrogel was stained with BacLight
Bacterial Viability Kit for L. lactis and
Viability/Cytotoxicity Kit, for MSCs. Both
kits stain viable cells in green (SYTO® 9 and
Calcein AM) and non-viable cells in red
(Propidium iodide and Ethidium
homodimer-1), a 50:50 mixture of the kits
were used for coculture. N > 5-10 microgels
were analyzed for each condition. Scale bar:
100 μm. (D) The viability graph of L. lactis,
MSCs, and coculture. MSCs, mesenchymal
stem cells.
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which resulted in microgel coalescence. It has also been noted that
monodispersity and tunability of their constructs are limited compared to
our droplet-based microfluidic platform in which liquid dispersion and
cross-linking all happens simultaneously.
As the two aqueous solution one carrying alginate and one carrying
Ca2þ meet at the tapered end of injection theta capillary, they simulta-
neously get focused within the laminar flow of mineral oil moving to-
wards collection outlet. Cross-linking happens as Ca2þ diffuses through
sodium alginate solution while microconstructs are formed under
laminar flow using a coflow focusing method. This dynamic system re-
sults in the formation of monodisperse but not symmetrical spherical
beads and pearls (Supplementary Fig. S1). It is important to point out that
alginate-calcium hydrogel as well as many other crossed linked hydrogels
are formed through diffusion of participating molecules. Because of the
time-dependent nature of diffusion, the homogeneity of any formed
construct can never be fully achieved. However, the smaller the construct
the smaller the difference would be across the formed hydrogel. Also, in
regard to cell distribution within the construct, the smaller the unit, on
average, the more homogeneous would be the spread of the cells across it
(see Supplementary Video 4).
The encapsulation is only achieved if cells are introduced via alginate
solution as small Ca2þ molecules diffuse across to large molecules of
alginate and not the other way around. Because ionic cross-linking occurs
extremely rapidly (ms), cells introduced via aqueous solution containing
calcium chloride would not be able to get entrapped in alginate network.
As a consequence, they dispersed into aqueous collection solution
together with excess water once no longer focused by mineral oil within
glass boundary of the collection capillary.
We used L. lactis as our prokaryotic and BM-MSCs as our eukaryotic
cell of interest. Initially, only one cell type was encapsulated in the
hydrogel for studying the viability and encapsulation efficiency (Sup-
plementary video of cell encapsulation, video 3). Either cell type once
introduced via the channel carrying the alginate solution was encapsu-
lated with well over 99% efficiency as shown in Fig. 2B. The measure-
ment was made over the course of 2 h by staining the collection media for
identifying cells that were not encapsulated.5The doubling time of wild-type L. lactis in cultures grown aerobically
is 32–34 min. Its fast proliferation rate in hydrogel as shown in Fig. S1(C)
was observed over the time course of three days. In the follow-up ex-
periments in order to keep the cell density of the bacteria at a stationary
phase, a combination of antibiotics (tetracycline and SMX) as well as a
lower metabolically active strain of L. lactis deficient in LDH were used
[32].
The volume of the pearl lace microgel is well defined, and hence, the
space is limited for a fast dividing L. lactis, with an initial concentration of
1 million cells per mL of media the L. lactis's viability was kept at
approximately 80% by two weeks of culturing (Fig. 2C–D, L. lactis in
basal media). With MSCs the viability over the same time period was
monitored to be well over 90% (Fig. 2C–D, MSCs in basal media).
Because the viability of MSCs was as high as week zero, we kept some of
the samples for longer (over four weeks) with no observed decreased in
viability.
The most commonly used methods for forming coculture spheroids as
3D in vitro models such as hanging drop [36], soft agar liquid overlay
[37], and functionalised microparticles [38] do not form monodisperse
constructs in terms of size, population density, and cell type ratio. As
shown in the supplementary videos (Supplementary Videos 3 and 4), we
have exploited microfluidic technology for fabrication of monodispersed
microgels in which the population of different cell types as well as their
ratio and distribution within the gels can be finely controlled.
Supplementary video related to this article can be found at https://
doi.org/10.1016/j.mtbio.2019.100011
For coculture studies, we used two constructs for L. lactis previously
reported by us [28]. The first of the two plasmids encodes the gene for an
FN fragment containing RGD integrin-binding motifs (FNIII 7-10) dis-
played as membrane protein. The second plasmid encodes the human
BMP-2 released into the extracellular medium by the bacteria. Both
constitutive and inducible, i.e. triggered by external stimuli (nisin),
versions of engineered genes were used for the following studies. Using
the microfluidic approach, three cell populations (MSCs, FNIII 7-10 dis-
playing L. lactis, and BMP-2 releasing L. lactis) were encapsulated into
microgels after getting mixing in the channel carrying alginate. The
fabricated microgels were incubated in culture medium at 37 C, 5%
K. Witte et al. Materials Today Bio 2 (2019) 100011CO2. The media was changed daily for two weeks. Microgels containing
MSC-only cells encapsulated in a similar way using either basal media
(negative control) or osteogenic media (positive control) were kept under
the same incubation conditions. Samples were taken at day zero, seven,
and fourteen. In single-cell studies, hydrogels were stained with BacLight
Bacterial Viability Kit for L. lactis and Viability/Cytotoxicity Kit, for
MSCs. Both kits stain viable cells in green (SYTO® 9 and Calcein AM) and
non-viable cells in red (Propidium iodide and Ethidium homodimer-1).
Note that either kit stained live cells green and dead cells red with no
apparent difference. In order to assure all cells are stained, a 50:50
mixture of both kits was used for staining cocultured samples, hence the
result is the viability of both cultures.
The viability of cocultured cells in week twowas lower (65%) than for
simple monocultures (Fig. 2C and D – MSC and L. lactis coculture). Note
that bacteria-only was >80% and MSC-only was >90% (Fig. 2C and D).
This is consistent with previous results that showed the viability of
L. lactis in cocultures to decrease slightly with time [28]. Because the
viability result of the coculture sample is a combination of two cell types,
the 65% lower reading cannot be further resolved to either cell
population.
3.3. Differentiation of MSCs in bacteria-laden microgels
To study the differentiation of MSCs within the bacteria-laden
microgels, samples were immunostained for the bone-specific ECM pro-
teins OPN as a marker for middle-stage differentiation and OCN as a
marker for late-stage differentiation [39,40]. As shown in Fig. 3,6significant high expression levels were observed for OCN (Fig. 3A) and
OPN (Fig. 3B) for samples of microgels containing MSCs and bacteria
compared to microgels gels containing only MSCs (week 2). This dem-
onstrates that microgels enable a commensalism symbiotic relationship
between bacteria and MSCs to trigger cell differentiation in confined 3D
microenvironments. Note that similar difference in expression of OPN
and OCN was observed between week two samples of positive (MSCs in
osteogenic media) and negative (in basal media) controls.
The local distribution of bacteria and MSCs within the microgels was
further investigated by SEM (Fig. 4). Whereas MSCs are distributed in
relatively empty microgels, with different cell morphology in depen-
dence of the use of basal or osteogenic medium, the coculture of both cell
populations involves intimate contact between eukaryotic and prokary-
otic cells. This result confirms the symbiotic relationship between both
cell population in confined spaces allowed by the microgels.
The synergistic signaling between growth factors and integrins
binding regions for enhancing stem cell differentiation has been exten-
sively studied in recent years [41,42]. In particular FN and its fragments
for engineering synergistic BMP-2 microenvironment for osteogenic
differentiation has been well documented [27]. In this experiment, we
explored the feasibility of our microgels—that maintain both population
of cells in intimate contact—to trigger the synergistic effect of both
populations of bacteria expressing FN and BMP-2 by encapsulating MSCs
with one of the two inducible L. lactis colonies for either expressing FNIII
7-10 fragment or BMP-2. We used inducible expression vectors for the
same two genes: BMP-2 and FNIII 7-10. L. lactiswere induced daily by 10
ng/mL nisin which has previously shown to sustain 200 ng/mL secretionFig. 3. Osteogenic differentiation of MSC
via bacteria expressing fibronectin and
BMP-2. (A) hBM-MSCs were immunostained
for osteocalcin (red), actin (green), and cell
nuclei (blue). Cells were cultured in basal
DMEM media with 2% FBS (top), with two
L. lactis strains constitutively producing
membrane-anchored FN and secreting BMP-
2 in basal DMEM media with 2% FBS (bot-
tom) and encapsulated in alginate hydrogel
in osteogenic media (middle). Total inte-
grated density corresponding to the red
channel (osteocalcin) was quantified using
ImageJ. Scale bar: 100 μm. (B) Samples from
same experiment were also immunostained
for osteopontin (red). (C) Graph shows
osteocalcin area per microgel with standard
deviation of the sample sets, N  10–20
microgels were analyzed for each condition.
Integrated density corresponding to osteo-
calcin was found to be significantly higher in
the bacteria-laden samples as well as samples
cultured in osteogenic media after two weeks
compared to MSCs without of bacteria. No
detectable signal was found for 0- and 1-
week old hydrogels. Data are presented as
mean  SD and analyzed with ANOVA with a
Tukey post hoc test. Significance levels are
*p < 0.05. (D) Graph showing similar trends
to osteocalcin immunostaining was observed
for osteopontin. MSCs, mesenchymal stem
cells; DMEM, Dulbecco's Modified Eagle
Medium; FBS, fetal bovine serum; FN, fibro-
nectin; BMP-2, bone morphogenetic protein-
2; ANOVA, analysis of variance; SD, standard
deviation; hBM-MSCs, human bone mar-
row–derived mesenchymal stem cells.
Fig. 4. SEM images of cell-laden alginate
constructs. Phase contrast images of algi-
nate microgels with MSCs in basal media (A);
alginate microgel with MSCs in osteogenic
media (B); alginate microgel with MSCs
containing two colonies of L. lactis (C) either
expressing FNIII 7-10 or BMP-2 in a consti-
tutive manner. Samples were fixed after two
weeks of culture. Scale bar: 100 μm. SEM
images of alginate construct with MSCs in
basal media, the images show mark
impressed by cell on the cross section of an
alginate construct (D); alginate microgel
with MSCs and two colonies of L. lactis
overpopulating the space (E); alginate
microgel with MSCs in osteogenic media,
round entities covering the cells, cavities and
fine membrane-like constructs (F). The
hydrogels were slightly dehydrated/
shrunken compared to their state in aqueous
media (see also Fig. S2). MSCs, mesenchymal
stem cells; SEM, scanning electron
microscope.
K. Witte et al. Materials Today Bio 2 (2019) 100011of BMP-2 over a 24 h period [28]. The concentration of BMP-2 is
maintained locally within the microgel. As shown in Fig. 5, the OPN and
OCN marker are more expressed in alginate construct containing either
BMP-2 or BMP-2 together with FNIII 7-10 compared to FNIII 7-10 only or7encapsulated MSCs without bacteria. The coculture containing both
BMP-2 and FNIII 7-10 shows significant increase in OPN as compared to
BMP-2 alone. The higher yet not significant readout for OCN was also
observed in the same comparison, hence further reaffirming theFig. 5. Osteogenic differentiation of MSCs
using both populations of bacterial
expressing fibronectin and BMP-2 as
observed by the expression of Osteopontin
and Osteocalcin. Phase contrast and fluores-
cent images of (A, F) MSCs encapsulated in
alginate hydrogel with no bacteria. (B, G)
MSCs with L. Lactis containing inducible
expression vector for producing membrane-
anchored FN. (C, H) MSCs with L. Lactis
containing inducible expression vector for
secreting BMP-2. (D, I) MSCs with both L.
lactis strains producing membrane-anchored
FN and secreting BMP-2. Hydrogels were
stained after two weeks for osteopontin
(red), actin is (green), DNA (blue). Scale bar:
100 μm. (E) Graph showing the production
of osteogenic markers osteopontin (OPN)
was significantly higher in MSCs with bac-
teria producing both FN and BMP-2 compare
to BMP-2 only. No detectable signal was
observed for FN only and control (no FN and
no BMP-2). (J) Similar graph for osteocalcin
(OCN) shows detectable signal for samples
containing bacteria which produces BMP-2.
However, no statistically significant differ-
ence in the OCN level was observed between
samples containing MSCs in with bacteria
producing both FN and BMP-2 compare to
BMP-2 only. No detectable signal was
observed for FN only and control (no FN and
no BMP-2). Graph shows osteopontin/osteo-
calcin area per microgel with standard devi-
ation of the sample sets, N  8–16 microgels
were analyzed for each condition. Data pre-
sented as mean  SD and analyzed with
ANOVA with a Tukey post hoc test. Signifi-
cance levels are *p < 0.05. MSCs, mesen-
chymal stem cells; FN, fibronectin; BMP-2,
bone morphogenetic protein-2; ANOVA,
analysis of variance; SD, standard deviation.
3 mm
Fig. 6. Bright-field and fluorescent im-
ages of pearl lace 3D printed simple ge-
ometries. The 3 mm in diameter circular
discs were laser cut through 3.00 mm acrylic
(PMMA) sheet and glued using epoxy on a
second 3.0 mm acrylic sheet. One-micron-
sized green (450/480) fluorescent poly-
styrene microspheres were encapsulated
within alginate pearl lace construct. The 90-
degree cross-sectional thickness varies from
10 μm at an interlinking unit between two
adjacent pearls to 50 μm across a pearl.
There are four rounds of thread in the tri-
angle geometry. The images were taken as a
scan over a 30  30 mm square (Supple-
mentary Fig. S3) using EVOS Fl Colour Cell
Imaging System at 10X objective and
stitched together using EVOS owns software.
K. Witte et al. Materials Today Bio 2 (2019) 100011enhanced osteogenic differentiation through the synergistic effect of both
expressed proteins in our micron-sized 3D hydrogel.
3.4. Pearl lace 3D printing
The unique interlinking pearl lace microstructure explored in this
study was used to create simple geometrical shapes (line, triangle,
square, and circle; Fig. 6 and S3). To demonstrate the encapsulation ef-
ficiency and the imaging of the transparent alginate-based microgel, one-
micron-sized fluorescent beads were encapsulated inside the construct
used for making geometrical shapes (Fig. 6). The thickness of the struc-
ture ranges from 10 μm at the interlinking unit between two adjacent
pearls to 50 μm at a pearl unit. Supplementary Video 5 demonstrates the
robustness of the thread made from this very thin microgel as it wraps
around a coverside.
Supplementary video related to this article can be found at https://
doi.org/10.1016/j.mtbio.2019.100011
4. Conclusion
Cell-laden micron-sized hydrogels as miniaturized natural microen-
vironments can be used for studying cellular behavior such as migration,
survival, proliferation, and differentiation in vitro [10,43]. Droplet
microfluidics technology is ideally suited for the construction of cell-la-
den microgels with micron size distributions. An inherent quality of
microfluidic systems is its reliability of producing monodisperse con-
structs which enables quantitative studies to be performed using them.
This feature in addition to their high data throughput give them a great
potential to contribute to fundamental biological studies, pharmacolog-
ical screenings, and personalized medicine [44]. In this study, we pro-
duced monodisperse alginate-based hydrogels encapsulating different
population of prokaryotic and eukaryotic cells using one-step8microfluidic fabrication. Benefiting from the fast gelation kinetics of
alginic acid with calcium, different hydrogel constructs were made.
Microfluidic parameters can be adjusted to have microconstructs in the
form of individual beads or linked together via a thread made of a same
material. The so-called linked beads in a shape of pearl lace structures
enables both the individual compartmentalization as seen in separate
capsules as well as being linked to other identical units via a highly
controllable link made from same material.
The connectivity of pearl lace hydrogels can provide a way of gradient
studies in which the population of each cell type and so its relative
density can be controlled. It can also be utilized for time-series indexing
studies as well as providing a mean for a low-cost, easy to fabricate 3D
bioprinting prototypes as demonstrated in this study.
Also because of their relatively small dimension, a few micrometers
thickness, they are readily compatible with standard microscopy tech-
niques without needing to be sectioned [6]. Sizes in microscale also offer
efficient material-to-cell volume ratios with improved nutrients by
diffusion over distances that are often on the order of millimeters [2].
This platform and the unique interlinking pearl lace microstructure has
the potential to form larger tissue constructs with homogeneous material
properties through cell-containing micromodules.
To conclude, we have engineered a microfluidic system for high
encapsulation efficiency and cell viability by recreating bacteria-based
materials [28] into a miniature scale. MSC differentiation is triggered
by bacteria cohabiting in the same compartmentalized microconstruct.
The cohabitation of both eukaryotic and prokaryotic cells in controllable
microenvironments has been explored as an in vitro examination model
with no in vivo prospect due to the potential potent immune response in
host to the presence of bacteria. Even though once cells are differenti-
ated, bacteria can be killed through a build-in kill switch [45] or anti-
biotic combination such as penicillin and streptomycin since bacteria
does not have resistance genes for either ones. Microgel in this study has
K. Witte et al. Materials Today Bio 2 (2019) 100011been utilized as a proof of concept for modeling a tuneable platform in
which both hydrogel acting as an ECM as well as production and release
of growth factor can be both engineered at a low cost with high precision
spatiotemporal control. It has been an attempt to further engineer more
aspects of an in vitro system, paving the way for study of cells and their
interaction with adjustable dynamic ECM-like environment with greater
control. This is a versatile encapsulation platform which enables cocul-
ture and concentration-dependent studies to be carried out in a unique
microcontrolled environment for MSC engineering. In this particular
model, it can also be utilized as a drug-screening platform once the
chemical profile of chemicals produced by bacteria is identified and
measured using spectroscopy against profile obtained from drug(s) of
interest.
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